Matisse Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Matisse Pharmaceuticals?

Matisse Pharmaceuticals has 3 investors including Brightlands Venture Partners And Chemelot Ventures.

Q: How much funding has Matisse Pharmaceuticals raised to date?

Matisse Pharmaceuticals has raised obfuscated.

Overview

Matisse Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Matisse Pharmaceuticals

CB Rank

97146

Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies.

Founded

obfuscation

Private

Venture - Series Unknown

Geleen, Limburg, The Netherlands

11-50

www.matisse-pharma.com/

Biopharma

Biotechnology

Life Science

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Bob Kool: Chief Executive Officer
Harry Relouw: Chief Financial Officer

Details

Legal Name

Matisse Pharmaceuticals B.V.

Operating Status

Active

Company Type

For Profit

About the Company

Matisse Pharmaceuticals is a biotechnology company dedicated to development of pharmaceutical therapies to treat disorders that are associated with fulminant inflammation such as sepsis. The most advanced product in development is the heparin fraction M6229 for the treatment of severe sepsis and septic shock.

Phone Number

+31 (0)88 2554 070

Contact Email

info@matisse-pharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Matisse Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Products & Services

M6229

A therapeutic product designed to neutralize toxic extracellular histones, targeting the treatment of sepsis.

Next Generation M6229

An advanced version of M6229 with an improved mechanism of action, aimed at treating multiple disease areas.

Research & Development

Matisse Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Matisse Pharmaceuticals	1	obfuscated obfuscation	Brightlands Venture Partners	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Brightlands Venture Partners	Yes	Venture Round - Matisse Pharmaceuticals	—
Brightlands Venture Partners	Yes	Venture Round - Matisse Pharmaceuticals	—
Brightlands Venture Partners	Yes	Venture Round - Matisse Pharmaceuticals	—
Brightlands Venture Partners	Yes	Venture Round - Matisse Pharmaceuticals	—
Brightlands Venture Partners	Yes	Venture Round - Matisse Pharmaceuticals	—